Corebridge Financial Schedules Announcement of Second Quarter 2024 Financial Results
Corebridge Financial Schedules Announcement of Second Quarter 2024 Financial Results
Corebridge Financial, Inc. (NYSE: CRBG) today announced that it will report second quarter 2024 financial results after the market closes on Wednesday, July 31, 2024. Corebridge earnings materials will be available in the Investors section of corebridgefinancial.com.
Corebridge will host a conference call at 10:00 a.m. EDT on Thursday, August 1, 2024, to review these results. The webcast can be accessed in the Investors section of corebridgefinancial.com, and a replay will be available shortly after the event.
About Corebridge Financial
Corebridge Financial, Inc. makes it possible for more people to take action in their financial lives. With more than $390 billion in assets under management and administration as of March 31, 2024, Corebridge Financial is one of the largest providers of retirement solutions and insurance products in the United States. We proudly partner with financial professionals and institutions to help individuals plan, save for and achieve secure financial futures. For more information, visit corebridgefinancial.com and follow us onLinkedIn and YouTube.
Işıl Müderrisoğlu (Investors): investorrelations@corebridgefinancial.com
Matt Ward (Media): media.contact@corebridgefinancial.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20240708209640/en/
-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks